|
213
|
625
|
8veoA |
Crystal structure of prmt5:mep50 in complex with mta |
|
200
|
625
|
8vewA |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 24 |
|
202
|
625
|
8veuA |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 23 |
|
206
|
625
|
8veyA |
Crystal structure of prmt5:mep50 in complex with mta and tng908 |
|
199
|
625
|
8vexA |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 28 |
|
216
|
622
|
8v9iA |
1-deoxy-d-xylulose 5-phosphate synthase (dxps) from deinococcus radiodurans with d-phenylalanine-derived triazole acetylphosphonate (d-phetrap) bound |
|
110
|
332
|
8sigA |
Crystal structure of prmt4 with compound yd1-288 |
|
76
|
303
|
8veuB |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 23 |
|
67
|
301
|
8vexB |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 28 |
|
71
|
310
|
8vetB |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 1 |
|
196
|
625
|
8vetA |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 1 |
|
75
|
302
|
8vewB |
Crystal structure of prmt5:mep50 in complex with mta and oxamide compound 24 |
|
104
|
331
|
8sihA |
Crystal structure of prmt4 with compound yd1-289 |
|
79
|
310
|
8veoB |
Crystal structure of prmt5:mep50 in complex with mta |
|
95
|
307
|
8shbA |
Crystal structure of prmt3 with compound yd1-208 |
|
73
|
303
|
8veyB |
Crystal structure of prmt5:mep50 in complex with mta and tng908 |
|
97
|
311
|
8shrA |
Crystal structure of prmt3 with compound yd1-214 |
|
91
|
306
|
8sioA |
Crystal structure of prmt3 with yd1-66 |
|
86
|
303
|
8xloA |
Fgfr1 kinase domain with a dual-warhead covalent inhibitor cxf-007 |
|
89
|
299
|
8xlqA |
Fgfr4 kinase domain with a dual-warhead covalent inhibitor cxf-007 |
|
100
|
337
|
8jotA |
Crystal structure of csf-1r kinase domain with sulfatinib |
|
94
|
306
|
8jmzA |
Fgfr1 kinase domain with sulfatinib |
|
78
|
274
|
8sv9A |
Crystal structure of ulk1 kinase domain with inhibitor mr-2088 |
|
169
|
462
|
8gktA |
Human mitochondrial serine hydroxymethyltransferase (shmt2) in complex with plp, glycine and agf320 inhibitor |
|
158
|
462
|
8gksA |
Human mitochondrial serine hydroxymethyltransferase (shmt2) in complex with plp, glycine and agf291 inhibitor |
|
170
|
462
|
8gkyA |
Human mitochondrial serine hydroxymethyltransferase (shmt2) y105f in complex with plp, glycine and agf359 inhibitor |
|
162
|
462
|
8gkzA |
Human mitochondrial serine hydroxymethyltransferase (shmt2) y105f in complex with plp, glycine and agf362 inhibitor |
|
153
|
462
|
8gkuA |
Human mitochondrial serine hydroxymethyltransferase (shmt2) in complex with plp, glycine and agf355 inhibitor |
|
164
|
462
|
8gkwA |
Human mitochondrial serine hydroxymethyltransferase (shmt2) in complex with plp, glycine and agf359 inhibitor |
|
108
|
328
|
8g2iA |
Crystal structure of prmt4 with compound yd1290 |
|
21
|
72
|
8iajC |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a) complex |
|
41
|
149
|
8iakD |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a-n71a) complex |
|
41
|
149
|
8iamD |
Cryo-em structure of the yeast spt-orm2 (orm2-s3d) complex |
|
142
|
555
|
8iamB |
Cryo-em structure of the yeast spt-orm2 (orm2-s3d) complex |
|
146
|
495
|
8iakA |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a-n71a) complex |
|
80
|
297
|
8uv0A |
Discovery of (4-pyrazolyl)-2-aminopyrimidines as potent and selective inhibitors of cyclin-dependent kinase 2 |
|
150
|
555
|
8iakB |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a-n71a) complex |
|
20
|
71
|
8iakC |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a-n71a) complex |
|
142
|
495
|
8iajA |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a) complex |
|
21
|
72
|
8iamC |
Cryo-em structure of the yeast spt-orm2 (orm2-s3d) complex |
|
145
|
495
|
8iamA |
Cryo-em structure of the yeast spt-orm2 (orm2-s3d) complex |
|
49
|
182
|
8iajD |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a) complex |
|
143
|
555
|
8iajB |
Cryo-em structure of the yeast spt-orm2 (orm2-s3a) complex |
|
64
|
277
|
8jf3A |
C-src in complex with compound 9 |
|
70
|
305
|
8u1fA |
Fgfr2 kinase domain bound to irreversible inhibitor cmpd 10 |
|
82
|
286
|
8udvA |
The x-ray co-crystal structure of human fgfr3 v555m and compound 17 |
|
84
|
288
|
8udtA |
The x-ray co-crystal structure of human fgfr3 and kin-3248 |
|
87
|
288
|
8uduA |
The x-ray co-crystal structure of human fgfr3 and compound 17 |
|
88
|
335
|
8u37A |
Crystal structure of the catalytic domain of human pkc alpha (d463n, v568i, s657e) in complex with nvp-cjl037 at 2.48-a resolution |
|
88
|
335
|
8uakA |
Crystal structure of the catalytic domain of human pkc alpha (d463n, v568i, s657e) in complex with darovasertib (nvp-lxs196) at 2.82-a resolution |
